CCEL vs SCHW · P/E 490, $39.6M cap vs P/E 19, rev $23.92B
CryoCell International Inc (CCEL) versus Charles Schwab Corp (SCHW) — a side-by-side from cached financials, not a winner call.
CryoCell International Inc (CCEL) is a medical care facilities company listed on US.
Charles Schwab Corp (SCHW) is a capital markets company listed on NYSE. It is led by Walt Bettinger.
CCEL does not have a complete income-statement cache yet.
Latest reported SCHW revenue for 2025-12-31 was $23.92B. Net income was $8.85B. Revenue was up 22.0% from 2024-12-31 to 2025-12-31. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
CCEL currently screens at market cap $39.6M and trailing P/E 490.0. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
Not investment advice. Open the CCEL and SCHW stock pages for the full models.
Not investment advice.